Global Orthobiologics Market Growth Analysis 2024 – Forecast Market Size And Key Factors Driving Growth

Overview and Scope

Orthobiologics refer to therapies derived from natural substances used to treat various musculoskeletal conditions. These therapies enhance the body’s ability to repair and regenerate bones, cartilage, tendons, and ligaments in orthopedic treatments. Their goal is to improve recovery times and outcomes in procedures such as spinal fusion, fracture repair, and joint reconstruction.

Sizing and Forecast

The orthobiologics market size has grown strongly in recent years. It will grow from $6.65 billion in 2023 to $7.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to the rise in prevalence of orthopedic diseases and conditions, shift towards minimally invasive procedures, rise in number of reconstructive surgeries, increase in healthcare expenditure, awareness among patients and healthcare providers, and economic development in emerging markets.

The orthobiologics market size is expected to see strong growth in the next few years. It will grow to $9.12 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the aging population and sedentary lifestyles, ongoing development of advanced products, favorable reimbursement policies, regulatory approvals for new orthobiologic products, and expanded indications for existing orthobiologic products. Major trends in the forecast period include advancements in regenerative medicine, product innovations, technological advancements, strategic initiatives, and market expansion.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

Segmentation & Regional Insights

The orthobiologics market covered in this report is segmented –

1) By Product Type: Viscosupplements, Bone Growth Factors, Demeneralized Bone Matrix, Synthetic Bone Substitutes, Cellular Allograft, Other Products
2) By Application: Spinal Fusion, Maxillofacial And Dental, Soft Tissue Repair, Reconstructive And Fracture Surgery, Other Applications
3) By End User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers , Other End Users

North America was the largest region in the orthobiologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16139&type=smp

Major Driver Impacting Market Growth

The increasing number of road accidents and sports injuries is expected to propel the growth of the orthobiologics market going forward. Road accidents and sports injuries refer to incidents causing physical harm to individuals, often involving the musculoskeletal system. Road accidents and sports injuries are fueled by factors such as distracted driving, speeding, poor road conditions for accidents, overuse, improper equipment, and lack of proper training for sports injuries. Orthobiologics help in the treatment of road accidents and sports injuries by promoting faster and more effective healing of musculoskeletal tissues, reducing inflammation, and enhancing the body’s natural repair processes through the use of substances such as bone grafts, growth factors, stem cells, and platelet-rich plasma. For instance, in May 2022, according to the National Highway Traffic Safety Administration, a US-based federal government agency focused on transportation safety, a 10.5% increase in motor vehicle crash fatalities was reported in 2021, estimating approximately 42,915 deaths compared to 38,824 in 2020. Therefore, the increasing number of sports injuries and road accidents will drive the orthobiologics market.

Key Industry Players

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

The orthobiologics market report table of contents includes:

1. Executive Summary
2. Orthobiologics Market Characteristics
3. Orthobiologics Market Trends And Strategies
4. Orthobiologics Market – Macro Economic Scenario
5. Global Orthobiologics Market Size and Growth
.
.
.
32. Global Orthobiologics Market Competitive Benchmarking
33. Global Orthobiologics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Orthobiologics Market
35. Orthobiologics Market Future Outlook and Potential Analysis
36. Appendix